IO-101

N/A

Report date: 2024/12/23 15:24:43

Base Information

Drug NameIO-101
Drug Alias NameIO-101
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCluster of differentiation 8 stimulants
TargetsCluster of differentiation 8
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIo Biotech Aps
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIo Biotech Aps
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungMelanoma

Other Information

ATC CodeN/A
Related LinksN/A